NCT07027709 Clinical Performance of Hybrid Ceramic Laminate Veneers
| NCT ID | NCT07027709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Bonding of Veneers After Different Treatment |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2025-06-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial evaluates the clinical performance of laminate veneers fabricated from HC hard blocks pretreated with BeautiBond Xtreme versus HC Primer, using BeautiLink SA cement. The study focuses on marginal adaptation, retention, discoloration, and recurrent caries over 18 months.
Eligibility Criteria
Inclusion Criteria:dult patients ≥ 21 years requiring laminate veneers in the esthetic zone, vital or endodontically treated teeth, sufficient enamel, willing and able to consent and comply. \- Exclusion Criteria: Periodontal disease, bruxism, poor hygiene, pregnancy, systemic illness, allergies, insufficient enamel, ongoing trials, orthodontic treatment. \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07027709 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Bonding of Veneers After Different Treatment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07027709 currently recruiting?
Yes, NCT07027709 is actively recruiting participants. Contact the research team at omniawafik@gmail.com for enrollment information.
Where is the NCT07027709 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07027709 clinical trial?
NCT07027709 is sponsored by Cairo University. The trial plans to enroll 28 participants.